Alpenglow Biosciences awarded $1.6M grant to develop AI-enabled smart microscopy and 3D database of cancer biopsies
Summary
Alpenglow is an inaugural recipient of Andy Hill grant, Cancer Research Endowment (CARE) fund to create AI-enabled 3D spatial biology of cancer biopsies Aims of the grant include developing a 3D database of prostate biopsies, automating segmentation and quantification of key structures including cancer cells and vessels, and developing smart microscopy techniques for automated detection of regions of interest using edge computing powered by NVIDIA 3D spatial biology imaging will be completed in collaboration with CorePlus, a leading pathology lab in for the inclusion of diverse populations in algorithmic training to minimize racial bias in algorithm developmentSEATTLE, Aug. 1, 2023 /PRNewswire/ -- has been awarded a $1.6M grant to develop artificial intelligence (AI) enabled smart microscopy using its patented multi-resolution 3Di platform for 3D spatial biology. "We are excited to continue to lead the field of 3D spatial biology and develop smart microscopy solutions to address cancer with this latest award," said Dr. Nicholas Reder, MD, MPH and CEO of Alpenglow Biosciences. Alpenglows 3D spatial biology platform can digitize entire tissue specimens rapidly, non-destructively, and provide AI-enabled quantitative analysis to answer key questions posed by clinicians and drug developers with higher accuracy and greater certainty. "Our team is thrilled to be advancing the transformation in pathology to incorporate 3D technology taking into consideration the inclusion of Hispanics to minimize racial bias in algorithm development," said Mariano de Socarraz, Founder and CEO at CorePlus. Alpenglow partners with pharmaceutical companies to bring better therapeutics to market faster through greater understanding of mechanism of action, efficacy & toxicology, and patient trial enrollment using their patented platform.